Please see full prescribing and safety information, including boxed warning, for VINORELBINE vials.
Available in:
- 10 mg per 1 mL single-dose vials
- 50 mg per 5 mL single-dose vials
Benefits:
- AP Rated
- Preservative-free
- Not made with natural rubber latex
Downloads:
VINORELBINE Injection, USP*
Brand Name Equivalent: NAVELBINE® (NAVELBINE is a registered trademark of Pierre Fabré Médicament Joint Stock Company)
Therapeutic Category: Antineoplastic Agent
PreventIV Measures® Features:
- Easy-to-read drug name and dosage strength to aid in identifying the right product
- Bar codes included on the vial and carton for ease of scanning
- Yellow and black cytotoxic caution flags on labels and cartons to alert caregivers who handle the product
| NDC #25021 |
Description | Strength | Fill Volume |
Concentration | Container Size |
Closure | Unit of Sale |
| 204-01 | Glass Vial | 10 mg | 1 mL | 10 mg per mL | 2 mL | 13 mm | 1 |
| 204-05 | Glass Vial | 50 mg | 5 mL | 10 mg per mL | 7 mL | 20 mm | 1 |
- Severe myelosuppression resulting in serious infection, septic shock, hospitalization and death may occur [see Warnings and Precautions (5.1)].
- Decrease the dose or withhold Vinorelbine in accord with recommended dose modifications [see Dosage and Administration (2.2)].
